The current publication aims to review and analyse the ethical aspects and regulations to protect the category of vulnerable patients, as defined in the European legislation. These patients need special protection and require more detailed approach throughout the clinical trials’ life cycle.
Part of the book: Clinical Trials in Vulnerable Populations